Search
Last updated: September 13.2019
https://www.alk.net/review-application
Review of applicationAccess to data may be provided following review of the application by a scientific review board including independent academic scientists and healthcare professionals.
The members of the scientific review board are:...
Last updated: November 28.2018
https://www.alk.net/status-applications
Status of applicationsNo applications have been received
Last updated: February 22.2019
https://www.alk.net/synopses
SynopsesALK sponsored clinical trial protocol information and results, regardless of outcome, are disclosed in publicly accessible clinical trial registries, for example EudraCT (clinicaltrialsregister.eu), clinicaltrials.gov or on this page....
Last updated: February 8.2019
https://www.alk.net/allergy-solutions-life
Updated ALK branding: Allergy solutions for lifeWe are a year into our transformation strategy, and ALK’s tagline and other branding materials have been updated to reflect our company’s expanded focus on reaching many more people with allerg...
Last updated: May 2.2019
https://www.alk.net/henning-lowenstein-research-award-2019
The ARIA-EUFOREA Henning Løwenstein Research Award 2019The Henning Løwenstein Research Award is a biennial award given to a young scientist who has shown excellence within the field of allergy.
Ca...
Last updated: December 5.2017
https://www.alk.net/strategy-usa
Growth strategy: Establish and succeed in North America Priority 1: North America is the world's largest allergy market, with over 50 million allergy sufferers, and it offers ALK the greatest medium-term growth potential. For example, t...
Last updated: December 5.2017
https://www.alk.net/strategy-complete-tablet-portfolio
Growth strategy: Complete the tablet portfolio for all relevant agesPriority 2: ALK is committed to offering a full portfolio of tablets for all relevant ages, covering the five most common global respiratory allergies....
Last updated: December 5.2017
https://www.alk.net/patient-engagement
Growth strategy: Patient engagement systems and adjacent businessPriority 3: ALK will establish a new commercial consumer care division to drive digital patient engagement with the ultimate aim of creating new value from ALK's expanded...
Last updated: December 5.2017
https://www.alk.net/strategy-optimise
Growth strategy: Optimise and reallocate ALK's resourcesPriority 4: Free up resources for new business and improve efficiency and structural effectiveness
ALK will improve efficiency by strengthening...
Last updated: January 11.2018
https://www.alk.net/feeling-ill-all-year-around
Feeling a bit ill all year around?If you rarely feel fully rested, have difficulties sleeping and sometimes wake up with red, sore eyes not feeling on top of the world, please keep on reading. Maybe you are one of the 250 million people arou...